Camila V Esguerra

Plain English
Researchers reviewed published studies on how U.S. state policies affect the health of transgender and gender-diverse teenagers. States with more inclusive policies consistently had lower rates of depression and suicidal thoughts among these youth. The findings point to a clear gap: policy-level research has focused almost entirely on state laws, leaving local and federal policy effects largely unstudied.

Plain English
This study tested a rapid diagnostic kit (the Idylla IDH1-2 Assay) for detecting IDH gene mutations in brain tumor tissue across 12 hospitals using stored patient samples. The kit agreed with standard lab methods 98.5% of the time and correctly identified all non-mutated samples. This matters because IDH mutation status determines how glioma patients are classified and treated, and a fast, reliable bedside test could speed up clinical decision-making.

Plain English
Pregnant people who screened positive for depression in early pregnancy were less likely to complete key third-trimester tests, specifically glucose tolerance and group B strep testing, compared to those without depression. They were also younger, less likely to have a partner, and more often publicly insured. Integrating mental health screening and support throughout pregnancy could help this vulnerable group avoid gaps in routine care.

Plain English
This study surveyed Hispanic/Latinx and Black teenagers in New York City with poorly controlled asthma about their beliefs in alternative remedies and their concerns about prescribed inhaled steroids. Most teenagers endorsed at least one alternative medicine belief, and Black adolescents were more likely to distrust their inhaled steroids than those who identified as both Hispanic/Latinx and Black. Healthcare providers should directly address these beliefs during asthma visits, tailoring conversations to each patient's cultural background.

Plain English
Researchers tested extracts and isolated compounds from a traditional African medicinal plant used for epilepsy in a zebrafish seizure model, identifying several xanthone compounds with seizure-suppressing activity. A crude extract and two individual compounds significantly reduced seizure-like behavior in the fish, while other compounds unexpectedly increased brain excitability. The results validate traditional uses of this plant and point to specific compounds worth developing further as potential anti-epileptic agents.

Plain English
Palmatine, a plant-derived compound, was tested across multiple zebrafish and mouse seizure models to assess its potential as an anti-epileptic drug. It reduced seizures in several models, including one that mimics drug-resistant epilepsy, and computer modeling suggests it may work by enhancing the brain's inhibitory signaling or blocking an excitatory receptor. However, palmatine did not prevent the long-term progression of epilepsy in mice and its precise mechanism remains unclear, so more work is needed before it can be considered a viable drug candidate.

Plain English
This qualitative study interviewed ten pregnant patients diagnosed with a breech or other malposition fetus to understand how they made decisions between cesarean delivery and a manual repositioning procedure. Patients wanted clearer statistics and more individualized information about the repositioning procedure, and fear of the unknown was the main reason many leaned toward cesarean. Providers should offer more detailed, patient-specific counseling to help people make informed choices that match their birth goals.

Plain English
This study introduced a new zebrafish model of epilepsy using pilocarpine, a drug that activates the same brain chemical pathway implicated in a common form of human epilepsy. Zebrafish exposed to pilocarpine developed electrical seizure activity in their brains and, after the drug wore off, continued to have spontaneous unprovoked seizures — mirroring the human condition. The model offers a faster, cheaper alternative to rodent epilepsy studies for testing new treatments.

Plain English
Twelve children with CHD2-related epilepsy — a drug-resistant form triggered by light — were treated with acetazolamide, a low-cost medication normally used as a diuretic. All twelve had their light-triggered seizures eliminated, and six became completely seizure-free; the drug also cut seizure activity by 72% in a zebrafish CHD2 model. Acetazolamide appears to be a promising and affordable option for this difficult-to-treat epilepsy, though larger studies are needed to confirm the findings.

Plain English
Researchers engineered zebrafish with reduced activity of the DHPS enzyme, which is essential for a rare chemical modification that helps the brain develop properly. These fish had smaller heads, abnormal body shapes, spontaneous seizure-like electrical activity, and fewer branches on inhibitory brain cells. The zebrafish model closely mirrors the human genetic disorder DHPS deficiency syndrome and provides a platform to study how the brain goes wrong and to test potential treatments.

Plain English
A plant extract from a New Caledonian endemic tree species, along with its key compound halfordin, was tested in zebrafish for seizure-blocking activity. Both the crude extract and pure halfordin significantly reduced convulsive behavior and electrical seizure activity in the fish brains, and halfordin altered expression of genes involved in brain excitability. These findings validate this plant's use in traditional medicine and identify halfordin as a promising lead for new anti-epileptic drug development.

Plain English
This study used in-depth interviews with 20 unvaccinated Hispanic adults at a free clinic in Florida to understand their hesitancy about COVID-19 vaccines. Three main themes emerged: distrust of information sources, personal factors like immigration status and prior health experiences, and a fear-based reluctance that nonetheless coexisted with openness to eventually getting vaccinated. Healthcare workers serving Hispanic communities can reduce hesitancy by addressing confusion through trusted messengers and acknowledging individual circumstances.

Plain English
Researchers tested whether activating the GPR39 receptor would reduce seizures, a hypothesis that had been proposed but not experimentally confirmed. Contrary to expectations, the GPR39 activator TC-G 1008 made seizures worse in both zebrafish and mice and accelerated the development of chronic epilepsy. The results argue against targeting GPR39 for epilepsy treatment and raise questions about whether TC-G 1008 acts exclusively through GPR39.

Plain English
This review examines how natural products — from plants, marine organisms, fungi, and microbes — have contributed to treating epilepsy that doesn't respond to standard medications. It covers recently approved drugs derived from nature, like cannabidiol and rapamycin, ongoing clinical trials, and dozens of preclinical candidates, with special attention to compounds that may work through the vagus nerve. The review argues that traditional medicine represents an underexplored reservoir of new epilepsy treatments with genuinely novel ways of acting in the brain.

Plain English
Schisandrin B, extracted from a traditional medicinal plant, reduced seizures in zebrafish larvae but failed to do so in mice, likely because very little of the drug reaches an active form in mouse brain tissue. Computer modeling suggested the compound acts on inhibitory and excitatory brain receptors, but toxicity tests showed it severely disrupts zebrafish development. These mixed results mean schisandrin B needs substantial further study before it could be considered for epilepsy treatment.

Plain English
A Norwegian birth cohort study measured 27 environmental chemicals in breast milk and tracked whether children developed autism. One pesticide, beta-hexachlorocyclohexane, was the only chemical linked to a significantly higher autism risk, and zebrafish experiments confirmed it disrupts the development of dopamine-producing neurons. Because Norwegian children's estimated daily intake through breastfeeding exceeds established safety thresholds, this finding highlights a public health concern warranting further investigation.

Plain English
Two compounds from a marine fungus, halimide and plinabulin, were found to block seizures in zebrafish and mice, including in models of drug-resistant epilepsy. Plinabulin is already in clinical trials for cancer-related side effects, raising the possibility of repurposing it for epilepsy. Testing related compounds that share plinabulin's mechanism of destabilizing cell structure but lack its seizure-blocking effect suggests the anti-seizure action comes from a different, as-yet-unknown mechanism.

Plain English
People carrying a specific genetic variant near the SCN1A gene (which controls brain sodium channels) showed higher SCN1A activity in their hippocampus and smaller hippocampal volume, suggesting this common variant raises epilepsy risk by turning the gene up rather than down. Zebrafish engineered to overexpress the equivalent gene had more frequent spontaneous seizures, and more copies meant more seizures. This finding is relevant to gene therapy approaches for Dravet syndrome, where increasing SCN1A is being explored as a treatment — too much may be as harmful as too little.

Plain English
A new synthetic compound was found to reduce seizures across four different mouse seizure models — including one that mimics drug-resistant epilepsy — while causing fewer movement-related side effects than existing drugs. Laboratory tests showed it works by enhancing the brain's main glutamate-clearing transporter (EAAT2), making it the first known drug to act this way. Its favorable absorption, metabolism, and safety profile make it a strong candidate for further development as a novel epilepsy treatment.

Plain English
Zebrafish carrying a mutation in the cacna1da gene — the fish equivalent of a gene linked to bipolar disorder and schizophrenia — showed abnormal hyperactivity that was not explained by anxiety or seizures. Antipsychotic drugs reversed the hyperactivity while an antiseizure drug only partially reduced it, pointing toward psychosis-like rather than epileptic behavior. These fish may provide a useful model for studying the brain mechanisms behind schizophrenia and testing new treatments.

Plain English
6-Gingerol, the main active compound in ginger, was isolated and tested in zebrafish larvae with chemically induced seizures. It reduced seizure-like behavior and electrical brain activity in a dose-dependent manner, and appeared to work by lowering glutamate — the brain's main excitatory chemical — and reducing activity at a key glutamate receptor. This is the first study to demonstrate anticonvulsant activity for 6-gingerol, suggesting ginger's traditional use for seizures may have a real pharmacological basis.

Plain English
A retrospective review at a New Jersey hospital found that 81% of women who requested permanent sterilization after delivery actually received the procedure. Cesarean delivery was by far the strongest predictor of completion, with 93% of those patients receiving the procedure compared to 66% of vaginal delivery patients; lacking insurance also reduced completion rates. The gap in access among vaginal delivery patients points to system- or provider-level barriers that future research should address.

Plain English
A synthetic hybrid compound called AS-1 was tested in multiple mouse and zebrafish models and showed broad anti-epileptic activity, including against drug-resistant seizures. When combined with valproic acid, the two drugs worked together better than either alone. The compound has excellent drug-like properties — it crosses the blood-brain barrier, is stable in human liver tissue, and shows no liver toxicity — making it a strong candidate for further development.

Plain English
Zebrafish with a partial knockdown of the cacna1aa gene — which controls calcium channels involved in absence seizures and episodic ataxia — developed spontaneous seizure-like electrical discharges in the brain. Several standard antiseizure drugs reduced these discharges, while carbamazepine had no effect, mirroring patterns seen in human absence epilepsy. This zebrafish model provides a new tool for studying calcium channel-related epilepsies and screening potential treatments.

Plain English
In a zebrafish model of Dravet syndrome — a severe childhood epilepsy — seizures were traced back to an imbalance in the ratio of excitatory to inhibitory neurons caused by reduced branching of inhibitory brain cells. The drug fenfluramine not only suppressed seizures but also fully restored the inhibitory cell structure and prevented abnormal cell proliferation, while the standard drug diazepam only reduced seizures without fixing the underlying damage. This suggests fenfluramine may modify the disease itself, not just manage symptoms.

Plain English
Palmatine, an alkaloid from barberry plants, was found to reduce chemically induced seizures in zebrafish, and combining it with the related compound berberine produced a stronger-than-additive effect. Both compounds cross into the brain and appear to work through different mechanisms, which may explain why together they replicated the anticonvulsant effect of the whole plant extract. The findings suggest that combining these two natural compounds could be more effective than either one alone for seizure control.

Plain English
This review comprehensively catalogues both chemical- and gene-based zebrafish models of epilepsy, comparing them to equivalent rodent and human data. Zebrafish offer unique advantages — fast development, transparent bodies, easy genetic manipulation, and suitability for large-scale drug screening — that complement but don't fully replace rodent models. The review argues zebrafish are underutilized and provides a practical reference to help researchers choose the right model for their epilepsy research question.

Plain English
This study developed a standardized, commercially available system to measure prepulse inhibition in zebrafish larvae — a test used to study sensory filtering deficits linked to schizophrenia and other brain disorders. Using this system, the team reproduced known drug effects seen in previous custom-built setups, validating the approach. Having a commercially accessible, reproducible protocol should make it easier for different laboratories to compare results and use zebrafish for neuropsychiatric drug research.

Plain English
Zebrafish-based screening of a traditional Congolese epilepsy remedy led researchers to identify indirubin — a compound that inhibits the enzyme GSK-3 — as the active ingredient responsible for seizure suppression. Both indirubin and a more potent GSK-3 inhibitor then blocked seizures in rat and mouse models, including a drug-resistant model. This is the first evidence that blocking GSK-3 reduces seizures, opening a new avenue for epilepsy drug development.

Plain English
Pterostilbene, a natural compound similar to resveratrol found in blueberries and grapes, reduced seizures in both zebrafish larvae and three separate mouse seizure models. Importantly, it did not impair movement or coordination in mice at effective doses. This is the first study to show pterostilbene has anti-epileptic properties, and while the exact mechanism is unknown, the results justify further investigation as a potential epilepsy treatment.

Plain English
Two mitochondrial proteins, NIPSNAP1 and NIPSNAP2, act as surface flags that mark damaged mitochondria for destruction by the cell's recycling machinery — a process called mitophagy. Zebrafish lacking functional NIPSNAP1 had reduced mitochondrial cleanup in the brain and developed features of Parkinson's disease, including loss of dopamine-producing neurons and reduced movement. This identifies these proteins as potential targets for therapies aimed at protecting neurons in Parkinson's and related diseases.

Plain English
This critical review surveys how zebrafish have been used to model schizophrenia, covering both drug-based and genetic approaches and weighing the strengths and limitations of the fish compared to rodents. While zebrafish reproduce several behavioral features of schizophrenia and allow rapid genetic manipulation, the authors argue that many models lack proper validation. They conclude that zebrafish have real potential for precision medicine and drug discovery in schizophrenia, but the field needs more rigorous standards.

Plain English
Two alkaloid compounds from a marine fungus, TMC-120A and TMC-120B, were identified through zebrafish-based screening and found to reduce seizures in both zebrafish and a mouse model of drug-resistant focal epilepsy. Three structurally related compounds from the same organism also showed seizure-blocking activity. The results demonstrate that marine fungi are a promising untapped source of new anti-epileptic drugs and that zebrafish findings can translate meaningfully to mammals.

Plain English
This opinion piece examines the largely unexplored connections between climate change and epilepsy, covering how rising temperatures, extreme weather, and the spread of infectious diseases could worsen seizure control and disrupt epilepsy care worldwide. The authors also note that the medical community's own carbon footprint — including international conference travel — contributes to the problem. They call for both more research into climate-epilepsy links and immediate action by healthcare professionals to reduce emissions.

Plain English
Zebrafish larvae were tested as a model for predicting whether drug compounds would damage the liver in humans, using a liver-specific gene as a readout. The zebrafish correctly distinguished between liver-toxic and non-toxic versions of the same chemicals and showed damage patterns consistent with human liver pathology, though toxicity in the heart could complicate readings. The results support zebrafish larvae as a useful early-stage screening tool for drug-induced liver injury, complementing standard cell-based tests.

Plain English
Analyzing genetic data from hundreds of people with photosensitive epilepsies, researchers found that rare variants in the CHD2 gene were significantly over-represented, particularly in a syndrome called eyelid myoclonia with absences. Zebrafish with reduced CHD2 activity showed dramatically heightened sensitivity to light-triggered seizure-like behavior. CHD2 is the first identified genetic cause of this epilepsy syndrome, and because it does not encode an ion channel, it opens entirely new research directions for understanding abnormal brain excitability.

Plain English
Zebrafish larvae and mice were treated with allylglycine, a compound that depletes the inhibitory brain chemical GABA, and the resulting seizures were tested against five standard anti-epileptic drugs. The seizure patterns and drug response profiles were strikingly similar between species, and most tested drugs showed limited effectiveness — mirroring what clinicians see in treatment-resistant human epilepsy. The authors propose allylglycine-treated zebrafish as a fast, cheap, and reliable model for screening new drugs against difficult-to-treat seizures.

Plain English
Zebrafish embryos engineered to have reduced activity of thyroid hormone-regulating enzymes (deiodinases) grew more slowly, moved less, had trouble inflating their swim bladders, and showed altered energy metabolism. Knocking down the thyroid-hormone-inactivating enzyme produced more severe effects than knocking down the activating enzymes, and both conditions impaired vision-related gene expression. The findings reveal how precisely balanced thyroid hormone levels must be during early vertebrate development and show zebrafish are a useful system for studying thyroid-related developmental disorders.

Plain English
Researchers created a zebrafish model of Dravet syndrome by silencing the gene equivalent to human SCN1A and documented spontaneous seizures and convulsive behavior in these fish. The serotonin-activating drug fenfluramine significantly reduced seizure-like electrical activity in the zebrafish brains, consistent with what has been observed in human clinical trials. This was the first animal model demonstration that fenfluramine can suppress seizures in Dravet syndrome, providing biological support for its use in patients.

Plain English
Zebrafish have two versions of the thyroid hormone-inactivating enzyme D3, and silencing them revealed that D3 is essential for normal early development — embryos without it developed more slowly, had abnormal organs including liver and intestine, and moved significantly less. The more highly expressed of the two genes had stronger effects when silenced, and the defects extended from physical malformations to impaired escape responses. The study establishes D3 as a critical developmental regulator and makes zebrafish a practical model for studying thyroid hormone-related developmental disorders.

Plain English
The protein SMOC2 was found to be necessary for the proper formation of early immune cells in zebrafish embryos, specifically a type of white blood cell produced in a region called the rostral blood islands. Without SMOC2, the molecular signals that normally instruct cells to become immune progenitors were disrupted. This work identifies SMOC2 as a key regulator of early blood cell development and connects it to a signaling pathway (BMP) that controls cell identity during embryogenesis.

Plain English
Using zebrafish with chemically induced seizures, researchers screened a traditional Philippine plant (Solanum torvum) and traced its anti-epileptic activity to a family of steroid-like sugar compounds isolated from the leaves. These compounds, also present in the traditional water-based preparation used in folk medicine, reduced seizures in zebrafish across multiple tests. The study demonstrates that zebrafish-guided fractionation can rapidly validate and decode the active ingredients in traditional seizure remedies.

Plain English
Wilson disease is a genetic condition where copper builds up and destroys the liver and brain; this study tested whether OSIP108, a short protein derived from plants, could protect against copper toxicity. OSIP108 improved cell survival in multiple lab models of Wilson disease and, when injected into copper-exposed zebrafish, restored normal liver structure and reduced damaging oxidative stress. These findings position OSIP108 as a lead compound for a new type of Wilson disease therapy.

Plain English
Ar-turmerone, a compound from turmeric, was further tested in mouse seizure models after it previously showed anti-epileptic activity in zebrafish. It reduced seizures in two mouse models, reached the brain quickly after injection, and showed no effect on motor coordination even at doses 500 times the effective amount. Combined with its ability to alter expression of seizure-related genes in zebrafish, ar-turmerone stands out as a well-tolerated natural compound warranting further study as a potential epilepsy treatment.

Plain English
A large screen of plant extracts in zebrafish embryos identified a compound called para-coumaric acid methyl ester (pCAME) that causes embryos to grow extra tails — a phenotype linked to disruption of signaling pathways that control body shape. Follow-up experiments showed pCAME works together with known inhibitors of the BMP pathway and causes the kind of movement defects seen when a related pathway (Wnt/PCP) is disrupted. While the exact molecular target was not pinned down, the zebrafish screen successfully flagged a biologically active natural compound worth further investigation.

Plain English
This survey study asked over 900 emergency department patients and family members what hospital resources they would expect to need during a pandemic, earthquake, or terrorist bombing. Expectations were high and sometimes unrealistic, and non-white individuals and those with more frequent hospital use consistently expected more services across all disaster types. The findings suggest that current hospital disaster plans may not match public expectations, and that targeted public communication — especially for underserved communities — is needed before disasters occur.